GSK headquarters
GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.

News Alert

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at